REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 11th, 2023 • Fusion Pharmaceuticals Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 11th, 2023 Company Industry JurisdictionThis REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of May 10, 2023 by and among Fusion Pharmaceuticals Inc., a corporation existing under the Canada Business Corporations Act (the “Company”), and the “Investors” named in that certain Securities Purchase Agreement by and among the Company and the Investors, dated as of May 10, 2023 (the “Purchase Agreement”). Capitalized terms used herein shall have the respective meanings ascribed thereto in the Purchase Agreement unless otherwise defined herein.
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • February 14th, 2023 • Fusion Pharmaceuticals Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 14th, 2023 Company Industry JurisdictionThis REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of February 13, 2023 by and among Fusion Pharmaceuticals Inc., a corporation existing under the Canada Business Corporations Act (the “Company”), and the “Investors” named in that certain Securities Purchase Agreement by and among the Company and the Investors, dated as of February 13, 2023 (the “Purchase Agreement”). Capitalized terms used herein shall have the respective meanings ascribed thereto in the Purchase Agreement unless otherwise defined herein.